Form 4: Tectonic Therapeutic CFO Receives Stock Grant
Insider Transaction (Form 4)
Daniel Lochner, Chief Financial Officer of Tectonic Therapeutic, Inc., received 24,250 shares of common stock on September 3, 2026.
Summary
- Grant/award: acquired 24,250 Employee Stock Option (Right to Buy) on September 3, 2026; holds 24,250 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Daniel Lochner — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-03 | Grant/award | Employee Stock Option (Right to Buy) | 24,250 | — | — | 24,250 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-03 | Grant/award (24,250 shares) |
Keywords
insider transaction, Form 4, TECX, Tectonic Therapeutic, Inc., neutral, Daniel Lochner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.